Browse the list below for project imagery.
Anoro Ellipta for Treatment of Chronic Obstructive Pulmonary Disease
Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Boostrix – Vaccine for Whooping Cough, Tetanus and Diphtheria
Breo Ellipta for Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype
Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Dulera (Mometasone Furoate and Formoterol Fumarate Dihydrate) - Treatment for Asthma
Flutiform (fluticasone proprionate and formoterol fumarate) for Treatment of Asthma
Incruse Ellipta for Chronic Obstructive Pulmonary Disease (COPD) Treatment
Kalydeco (Ivacaftor) - Treatment for Cystic Fibrosis
NicVAX for Nicotine Addiction
Ofev (nintedanib) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Pirfenidone – Treatment for Idiopathic Pulmonary Fibrosis
Rapamune (sirolimus) for the Treatment of Lymphangioleiomyomatosis (LAM)
Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB)
Sirturo tablets are available in 100mg dosage for oral administration.
The FDA approval for Sirturo was based on two Phase II clinical studies.
The TMC207-C208 clinical studies on Sirturo enrolled more than 440 patients...
Janssen will initiate Phase III clinical trials on Sirturo in the first half...